| First Author (yr) | Title | Citation | Data |
|---|
| Abecasis (2007) |
Recombination confounds the early evolutionary history of human immunodeficiency virus type 1: subtype G is a circulating recombinant form |
J Virol |
|
| Adachi (1986) |
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. |
J Virol |
|
| Adojaan (2005) |
Predominance of a Rare Type of HIV-1 in Estonia |
JAIDS |
|
| Aghokeng (2007) |
Full-length sequence analysis of SIVmus in wild populations of mustached monkeys (Cercopithecus cephus) from Cameroon provides evidence for two co-circulating SIVmus lineages |
Virology |
|
| Agwale (2006) |
Genotypic and phenotypic analyses of human immunodeficiency virus type 1 in antiretroviral drug-naive Nigerian patients. |
ARHR |
|
| Ait-Khaled (2002) |
Mutations in HIV-1 reverse transcriptase during therapy with abacavir, lamivudine, zidovudine in HIV-1 infected adults with no prior antiretroviral therapy |
Antiviral Therapy |
|
| Albert (1987) |
A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB. |
ARHR |
|
| Albert (1992) |
Persistence of azidothymidine-resistant human immunodeficiency virus type 1 RNA genotypes in posttreatment sera. |
J Virol |
|
| Albert (1994) |
Analysis of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes. |
J Virol |
|
| Albrecht (2000) |
Effect of lamivudine in HIV-infected persons with prior exposure to zidovudine/didanosine or zidovudine/zalcitabine. |
ARHR |
|
| Albrecht (2001) |
Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection.(AIDS Clinical Trials Group 364 Study Team) |
N Engl J Med |
|
| Alizon (1986) |
Genetic variability of the AIDS virus: Nucleotide sequence analysis of two isolates from African patients. |
Cell |
|
| Allen (2005) |
Selective Escape from CD8+ T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and Reveals Constraints on HIV-1 Evolution |
J Virol |
|
| Anderson (2000) |
Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E. |
J Virol |
|
| Andersson (1999) |
Molecular characterization of human immunodeficiency virus (HIV)-1 and -2 in individuals from Guinea-Bissau with single or dual infections: Predominance of a distinct HIV-1 subtype A/G recombinant in West Africa. |
Virology |
|
| Andresen (2007) |
Characterization of near full-length genomes of HIV type 1 strains in Denmark: basis for a universal therapeutic vaccine |
ARHR |
|
| Andries (2004) |
TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1 |
AAC |
|
| Apetrei (1998) |
Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility. |
J Virol |
|
| Apetrei (2003) |
HIV type 1 diversity in northeastern Romania in 2000-2001 based on phylogenetic analysis of pol sequences from patients failing antiretroviral therapy |
ARHR |
|
| Apetrei (2005) |
Molecular Epidemiology of Simian Immunodeficiency Virus SIVsm in U.S. Primate Centers Unravels the Origin of SIVmac and SIVstm |
J Virol |
|
| Arien (2005) |
Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time |
AIDS |
|
| Ariyoshi (2003) |
Patterns of point mutations associated with antiretroviral drug treatment failure in CRF01_AE (subtype E) infection differ from subtype B infection. |
JAIDS |
|
| Arnold (1995) |
At least five HIV-1 sequence subtypes (A, B, C, D, A/E) occur in England. |
ARHR |
|
| Arroyo (2004) |
HIV Type 1 Subtypes among Blood Donors in the Mbeya Region of Southwest Tanzania |
ARHR |
|
| Arroyo (2005) |
HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania |
AIDS |
|
| Atkinson (2000) |
Correlation between human immunodeficiency virus genotypic resistance and virologic response in patients receiving nelfinavir monotherapy or nelfinavir with lamivudine and zidovudine |
J Infect Dis |
|
| Aulicino (2005) |
Sequence Analysis of a South American HIV Type 1 BC Recombinant |
ARHR |
|
| Aulicino (2005) |
Circulation of novel HIV type 1 A, B/C, and F subtypes in Argentina |
ARHR |
|
| Auwanit (1999) |
Full-length sequences of two isolates of HIV-1 subtype E from 1995 samples of patients with sexually transmitted diseases in Thailand. |
ARHR |
|
| Azevedo-Pereira (1998) |
Complete nucleotide sequence of HIV-2ALI, a low infectious isolate with restricted tropism to primary CD4+ cells. |
GenBank submission |
|
| Babic (2006) |
Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naive patients in Slovenia, 2000-2004 |
Virus Res |
|
| Bacheler (2000) |
Human imunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy. |
AAC |
|
| Bacheler (2001) |
Genotypic correlates of phenotypic resistance to Efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy |
J Virol |
|
| Badreddine (2007) |
Identification and Characterization of HIV Type 1 Subtypes Present in the Kingdom of Saudi Arabia: High Level of Genetic Diversity Found |
ARHR |
|
| Baier (1990) |
Complete nucleotide sequence of a simian immunodeficiency virus from African green monkeys: A novel type of intragroup divergence. |
Virology |
|
| Balakrishnan (2005) |
HIV type 1 genotypic variation in an antiretroviral treatment-naive population in southern India |
ARHR |
|
| Baldrich-Rubio (2001) |
A complex human immunodeficiency virus type 1 A/G/J recombinant virus isolated from a seronegative patient with AIDS from Benin, West Africa |
J Gen Virol |
|
| Balotta (2000) |
Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a multicenter cohort of HIV-1 infected Italian patients with virologic failure |
JAIDS |
|
| Balotta (2000) |
Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region, outcome after treatment in recently infected individuals. |
Antiviral Therapy |
|
| Balotta (2001) |
Increasing prevalence of non-clade B HIV-1 strains heterosexuals, as monitored by the analysis of the RT and protease sequences |
JAIDS |
|
| Balzarini (1998) |
A novel mutation (F227L) arises in the reverse transcriptase of human immunodeficiency virus type 1 on dose-escalating treatment of HIV type 1-infected cell cultures with the nonnucleoside reverse transcriptase inhibitor thiocarboxanilide UC-781. |
ARHR |
|
| Bang (2008) |
Prevalence of primary antiretroviral resistance: trends in Korea |
ARHR |
|
| Barditch-Crovo (2001) |
Phase I/II trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults |
AAC |
|
| Barlow (2003) |
Characterization of a novel simian immunodeficiency virus(SIVmonNG1) genome sequence from a mona monkey(cercopithecus mona) |
J Virol |
|
| Barnett (1993) |
Distinguishing features of an infectious molecular clone of the highly divergent and noncytopathic human immunodeficiency virus type 2 UC1 strain. |
J Virol |
|
| Barnett (1996) |
Molecular cloning of the human immunodeficiency virus subtype 2 strain HIV-2-UC2. |
Virology |
|
| Barreto (2006) |
Trends in antiretroviral drug resistance and clade distributions among HIV-1--infected blood donors in Sao Paulo, Brazil. |
JAIDS |
|
| Baxter (2000) |
A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 study team for the Terry Beirn community programs for Clinical research on AIDS. |
AIDS |
|
| Baxter (2006) |
Genotypic changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir. |
J Virol |
|
| Bazmi (2000) |
In vitro selection of mutations in the human immunodeficiency virus type 1 reverse transcriptase that decrease susceptibility to (-)-beta-D-dioxolane-guanosine and suppress resistance to 3'-azido-3'-deoxythymidine. |
AAC |
|
| Becker (1995) |
Direct Genbank Submission: Molecular and phylogenetic characterisation of a Guineau-Bissau-derived human immunodeficiency virus type 2 isolate. |
unpublished |
|
| Becker-Pergola (2000) |
Analysis of HIV Type 1 protease and reverse transcriptase in antiretroviral drug naive Ugandan adults. |
ARHR |
|
| Beer (1999) |
Simian Immunodeficiency Virus (SIV) from Sun-Tailed Monkeys (Cercopithecus solatus): Evidence for Host-Dependent Evolution of SIV within the C.lhoesti Superspecies. |
J Virol |
|
| Beer (2000) |
Patterns of genomic sequence diversity among their simian immunodeficiency viruses suggest that L'Hoest monkeys (Cercopithecus lhoesti) are a natural lentivirus reservoir |
J Virol |
|
| Beer (2001) |
Characterization of novel simian immunodeficiency viruses from red-capped mangabeys from Nigera |
J Virol |
|
| Beerenwinkel (2002) |
Diversity and complexity of HIV-1 drug resistance: A bioinformatics approach to predicting phenotype from genotype |
PNAS |
|
| Belec (2000) |
High levels of drug resistance human immuno deficiency virus variants in patients exhibiting increasing CD4 + t cell counts despite virologic failure of protease inhibitors containing antiretroviral combination therapy. |
J Infect Dis |
|
| Bellosillo (2003) |
G190A substitution is associated with delavirdine(DLV) hypersusceptibility in vitro and clinical response with DLV intensification |
Antiviral Therapy |
|
| Benn (1985) |
Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire. |
Science |
|
| Benveniste (1988) |
Inoculation of baboons and macaques with simian immunodeficiency virus/Mne, a primate lentivirus closely related to human immunodeficiency virus type 2. |
J Virol |
|
| Bernardin (2003) |
Primary Infection of a Male Plasma Donor with Divergent HIV Variants from the Same Source Followed by Rapid Fluctuations in Their Relative Frequency and Viral Recombination |
ARHR |
|
| Bernardin (2005) |
Direct GenBank Submission: HIV-1 Isolates from Canada, Primary Infection |
unpublished |
|
| Bernardin (2005) |
Human immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes |
J Virol |
|
| Bessong (2005) |
Characterization of human immunodeficiency virus type 1 from a previously unexplored region of South Africa with a high HIV prevalence. |
ARHR |
|
| Bessong (2006) |
Resistance Mutational Analysis of HIV Type 1 Subtype C among Rural South African Drug-Naive Patients Prior to Large-Scale Availability of Antiretrovirals |
ARHR |
|
| Bibollet-Ruche (2004) |
Complete genome analysis of one of the earliest SIVcpzPtt strains from Gabon (SIVcpzGAB2). |
ARHR |
|
| Bibollet-Ruche (2004) |
New simian immunodeficiency virus infecting De Brazza's monkeys (Cercopithecus neglectus): evidence for a cercopithecus monkey virus clade. |
J Virol |
|
| Blankson (2007) |
Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors |
J Virol |
|
| Bleiber (2001) |
Individual contributions of mutant protease and reverse transcriptase to viral infectivity, replication, and protein maturation of antiretroviral drug-resistant human immunodeficiency virus type 1 |
J Virol |
|
| Bodelle (2004) |
Identification and genomic sequence of an HIV type 1 group N isolate from Cameroon. |
ARHR |
|
| Bonhoeffer (2004) |
Evidence for positive epistasis in HIV-1 |
Science |
|
| Bonnenfant (2004) |
Styrylquinolines, integrase inhibitors acting prior to integration: a new mechanism of action for anti-integrase agents |
J Virol |
|
| Bouchard (2007) |
HIV type 1 drug resistance among naive patients from Venezuela |
ARHR |
|
| Boucher (1993) |
High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase. |
AAC |
|
| Boucher (1996) |
Human immunodeficiency virus type 1 drug susceptibility determination by using recombinant viruses generated from patient sera tested in a cell-killing assay. |
AAC |
|
| Bouzeghoub (2006) |
High diversity of HIV type 1 in Algeria |
ARHR |
|
| Bradshaw (2007) |
Characterization of a novel drug-resistance pattern associated with the mutations K70G and M184V in HIV-1 reverse transcriptase |
AAC |
|
| Brandin (2003) |
Pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy |
ARHR |
|
| Brann (2006) |
Functional correlation between a novel amino acid insertion at codon 19 in the protease of human immunodeficiency virus type 1 and polymorphism in the p1/p6 Gag cleavage site in drug resistance and replication fitness |
J Virol |
|
| Brennan (2000) |
Genetic variation in human immunodeficiency virus type 2: identification of a unique variant from human plasma. |
ARHR |
|
| Brennan (2007) |
HIV-1 strains identified in Brazilian blood donors: significant prevalence of B/F1 recombinants |
ARHR |
|
| Brennan (2008) |
The Prevalence of Diverse HIV-1 Strains Was Stable in Cameroonian Blood Donors From 1996 to 2004 |
JAIDS |
|
| Brenner (2003) |
A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors |
AIDS |
|
| Brenner (2006) |
HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture |
AIDS |
|
| Brigido (2007) |
HIV type 1 subtype C and CB Pol recombinants prevail at the cities with the highest AIDS prevalence rate in Brazil |
ARHR |
|
| Brillant (2004) |
In vitro Resistance Development for a second generation NNRTI: TMC125 |
unpublished |
|
| Brindeiro (2002) |
Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 Isolates of Clade B and Other Clades from Children Failing Antiretroviral Therapy |
J Clin Microbiol |
|
| Brindeiro (1999) |
Sequence diversity of the reverse transcriptase of human immunodeficiency virus type 1 from untreated Brazilian individuals. |
AAC |
|
| Brindeiro (2003) |
Brazilian network for HIV drug resistance surveillance (HIV-BResNet): a survey of chronically infected individuals |
AIDS |
|
| Briones (2000) |
Dynamics of dominance of a dipeptide insertion in reverse transcriptase of HIV-1 from patients subjected to prolonged therapy. |
Virus Res |
|
| Brown (2000) |
Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites. |
J Virol |
|
| Brown (2005) |
Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines. |
J Virol |
|
| Brumme (2007) |
Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1 |
PLoS Pathog |
|
| Brun (2001) |
Patterns of protease inhibitor cross resistance in viral isolates with reduced susceptibility to lopinavir |
8th CROI |
|
| Burns (2002) |
Sequence variability of the integrase protein from a diverse collection of HIV type 1 isolates representing several subtypes |
ARHR |
|
| Bussmann (2005) |
HIV-1 subtype C drug-resistance background among ARV-naive adults in Botswana. |
Antivir Chem Chemoth |
|
| Buzon (2008) |
Raltegravir susceptibility and fitness progression of HIV type-1 integrase in patients on long-term antiretroviral therapy |
Antiviral Therapy |
|
| Byrnes (1993) |
Comprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitors. |
AAC |
|
| Byrnes (1994) |
Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitors. |
AAC |
|
| Cabana (1999) |
Emergence and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors. |
J Med Virol |
|
| Cahn (2002) |
Patients infected with nonB isolates from Argentina |
Unpublished |
|
| Cain (1999) |
RT and protease sequences from heavily treated patients referred to a reference lab in the UK. |
unpublished |
|
| Cali (2005) |
Evidence for host-driven selection of the HIV type 1 vpr gene in vivo during HIV disease progression in a transfusion-acquired cohort |
ARHR |
|
| Camacho (2002) |
Patients infected with Non-B isolates from Portugal |
Unpublished |
|
| Candotti (1999) |
AIDS in a HIV antibody seronegative Ghanaian woman |
J Med Virol |
|
| Caride (2001) |
Genotypic and phenotypic evidence of different drug-resistance mutation patterns between B and non-B subtype isolates of human immunodeficiency virus type 1 found in Brazilian patients failing HAART |
Virus Genes |
|
| Caron (2008) |
Human immunodeficiency virus type 1 seroprevalence and antiretroviral drug resistance-associated mutations in miners in Gabon, central Africa |
ARHR |
|
| Carr (1996) |
Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand. |
J Virol |
|
| Carr (1998) |
Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants |
Virology |
|
| Carr (1999) |
Direct Genbank Submission: HIV-1 isolates from the Democratic Republic of the Congo and from Gabon. |
unpublished |
|
| Carr (1999) |
Characterization of subtype A HIV-1 from Africa by full genome sequencing. |
AIDS |
|
| Carr (2001) |
The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon |
Virology |
|
| Carr (2001) |
Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America |
AIDS |
|
| Carr (2005) |
Direct Genbank Submission: HIV Subtype and Drug Resistance Patterns among Drug-Naive Infected Persons in Jos, Nigeria. |
Unpublished |
|
| Carr (2005) |
Outbreak of West African recombinant of HIV-1 in Tashkent, Uzbekistan. |
JAIDS |
|
| Carr (2006) |
Direct Genbank Submission: High Genetic Complexity of HIV-1 in low-prevalence, rural regions of Cameroon. |
unpublished |
|
| Carrillo (1998) |
In vitro selection and characterization of human immunodeficiency virus type 1 variants with increased resistance to ABT-378. |
J Virol |
|
| Carrion (2003) |
Circulating Recombinant Form CRF02_AG in South America |
ARHR |
|
| Carrion (2004) |
Documentation of subtype C HIV Type 1 strains in Argentina, Paraguay, and Uruguay |
ARHR |
|
| Casado (2003) |
Near Full-Length Genome Characterization of an HIV Type 1 CRF05_DF Virus from Spain |
ARHR |
|
| Casado (2005) |
Identification of a novel HIV-1 circulating ADG intersubtype recombinant form (CRF19_cpx) in Cuba |
JAIDS |
|
| Castro (2002) |
Molecular epidemiology of HIV-1 in Venezuela: High prevalence of HIV-1 subtype B and identification of an B/F recombinant infection |
JAIDS |
|
| Caumont (2001) |
Sequence analysis of env C2/V3, gag p17/p24, and pol protease regions of 25 HIV type 1 Isolates from Ho Chi Minh city, Vietnam |
ARHR |
|
| Cenci (1997) |
Selected nucleotide sequence of the pol gene of the monocytotropic strain HIV-1 BAL. |
ARHR |
|
| Chaix (2003) |
Stable prevalence of genotypic drug resistance mutatioins but increase in non-B virus among patients with primary HIV-1 infection in France |
AIDS |
|
| Chakrabarti (1987) |
Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. |
Nature |
|
| Chang (1999) |
Sequence features downstream of the primer-binding site of HIV type 1 subtype E shared by subtype G and a subset of subtype A |
ARHR |
|
| Chang (1999) |
Differential stability of the mRNA secondary structures in the frameshift site of various HIV type 1 viruses. |
ARHR |
|
| Charpentier (2008) |
Drug resistance profiles for the HIV integrase gene in patients failing raltegravir salvage therapy |
HIV Med |
|
| Chen (1996) |
Genetic characterization of new West African simian immunodeficiency virus SIVsm: geographic clustering of household-derived SIV strains with human immunodeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty mangabey t |
J Virol |
|
| Cheng (1992) |
Molecular characterization of HIV-2(ROD) protease following PCR cloning from virus infected H9 cells |
Adv. Exp. Med. Biol |
|
| Cho (1998) |
Direct Genbank Submission: Complete HIV-1 Genome from South Korea, long-term nonprogressor. |
unpublished |
|
| Cho (2002) |
Frequency of mutations conferring resistance to nucleoside reverse transcriptase inhibitors in human immunodeficiency virus type 1-infected patients in Korea. |
J Clin Microbiol |
|
| Cho (2006) |
High frequency of grossly deleted nef genes in HIV-1 infected long-term slow progressors treated with Korean red ginseng |
Curr HIV Res |
|
| Choi (1997) |
HIV type 1 isolate Z321, the strain used to make a therapeutic HIV type 1 immunogen, is intersubtype recombinant |
ARHR |
|
| Chou (1999) |
HIV-1 RT and protease sequences from individuals failing antiretroviral therapy, Portland VAMC. |
unpublished |
|
| Church (2007) |
HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D |
ARHR |
|
| Ciccozzi (2005) |
Molecular diversity of HIV in Albania |
J Infect Dis |
|
| Cinque (2001) |
Effect of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid. |
ARHR |
|
| Clavel (1986) |
Isolation of a new human retrovirus from West African patients with AIDS. |
Science |
|
| Clavel (1986) |
Molecular cloning and polymorphism of the human immunodeficiency virus type 2. |
Nature |
|
| Clevenbergh (2002) |
Long-term virological outcome in patients infected with multi-nucleoside analogue-resistant HIV-1. |
Antiviral Therapy |
|
| Clewley (1998) |
A novel simian immunodeficiency virus (SIVdrl) pol sequence from the drill monkey, Mandrillus leucophaeus. |
J Virol |
|
| Clewley (2005) |
Direct Genbank Submission: Partial pol gene from SIV found in Mandillus leuophaeus. |
unpublished |
|
| Coakley (2005) |
Atazanavir resistance in a protease inhibitor-naïve patient treated with Atazanavir/Ritonavir associated with development of high-level Atazanavir resistance and the N88S mutation in protease. |
unpublished |
|
| Coakley (2000) |
Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine. |
AIDS |
|
| Collman (1992) |
An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. |
J Virol |
|
| Colonno (2000) |
BMS-232632 sensitivity of a panel of HIV-1 clinical isolates resistant to one or more approved protease inhibitors. |
Antiviral Therapy |
|
| Colonno (2004) |
Identification of I50L as the signature atazanavir (ATV)-resistance mutation in treatment-naive HIV-1-infected patients receiving ATV-containing regimens. |
J Infect Dis |
|
| Condra (1995) |
In vivo emergence of HIV-1 variants resistant to multiple protease Inhibitors |
Nature |
|
| Condra (1996) |
Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor |
J Virol |
|
| Corbet (2000) |
Env sequences of SIV from chimpanzees in Cameroon are strongly related to HIV group N from the same geographic area. |
J Virol |
|
| Cornelissen (1997) |
pol diversity of five HIV-1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D. |
J Virol |
|
| Cornelissen (2000) |
Spread of distinct human immunodeficiency virus type 1 AG recombinant lineages in Africa |
J Gen Virol |
|
| Courgnaud (1992) |
Genetic differences accounting for evolution and pathogenicity of simian immunodeficiency virus from a sooty mangabey monkey after cross-species transmission to a pig-tailed macaque. |
J Virol |
|
| Courgnaud (2001) |
Characterization of a novel simian immunodeficiency virus from guereza colobus monkeys (Colobus guereza) in Cameroon: a new lineage in the nonhuman primate lentivirus family. |
J Virol |
|
| Courgnaud (2002) |
Characterization of a novel simian immunodeficiency virus with a vpu gene from greater spot-nosed monkeys (Cercopithecus nictitans) provides new insights into simian/human immunodeficiency virus phylogeny. |
J Virol |
|
| Courgnaud (2003) |
Partial molecular characterization of two simian immunodeficiency viruses (SIV) from African colobids: SIVwrc from western red colobus (Piliocolobus badius) and SIVolc from olive colobus (Procolobus verus). |
J Virol |
|
| Courgnaud (2003) |
Identification of a new simian immunodeficiency virus lineage with a vpu gene present among different cercopithecus monkeys (C. mona, C. cephus, and C. nictitans) from Cameroon. |
J Virol |
|
| Couto-Fernandez (2006) |
Phylogenetic Analysis of Brazilian HIV Type 1 Subtype D Strains: Tracing the Origin of This Subtype in Brazil |
ARHR |
|
| Craig (1998) |
HIV protease genotype and viral sensitivity to HIV protease inhibitors following saquinavir therapy. |
AIDS |
|
| Crandall (1999) |
Parallel evolution of drug resistance in HIV: Failure of nonsynonymous / synonymous substitution rate ratio to detect selection. |
Mol Bio Evol |
|
| Cuevas (2002) |
High HIV-1 genetic diversity in Cuba. |
AIDS |
|
| Damond (2004) |
Identification of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification. |
ARHR |
|
| Das (2004) |
Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 varian |
J Med Chem |
|
| Das (2008) |
High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: strategic flexibility explains potency against resistance mutations |
PNAS |
|
| Dauber (2002) |
Altered substrate specificity of drug-resistant human immunodeficiency virus type 1 protease. |
J Virol |
|
| Dazza (2005) |
Characterization of a Novel vpu-Harboring Simian Immunodeficiency Virus from a Dent's Mona Monkey (Cercopithecus mona denti) |
J Virol |
|
| de Baar (2000) |
Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo |
ARHR |
|
| De Leys (1989) |
Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of West-Central African origin. |
J Virol |
|
| De Meyer (2008) |
Characterization of virologic failures on darunavir/ritonavir in the randomized, controlled, Phase III TITAN trial in treatment-experienced patients |
15th CROI |
|
| de Sa Filho (2002) |
Mutations associated with drug resistance in a population of drug naive HIV-1 infected individuals |
GenBank submission |
|
| de Sa Filho (2003) |
Analysis of the protease sequences of HIV-1 infected individuals after Indinavir monotherapy. |
J Clin Virol |
|
| de Sa Filho (2005) |
Analysis of full-length human immunodeficiency virus type 1 genome reveals a variable spectrum of subtypes B and f recombinants in Sao Paulo, Brazil |
ARHR |
|
| de Sa Filho (2006) |
Identification of two HIV type 1 circulating recombinant forms in Brazil |
ARHR |
|
| de Sa Filho (2008) |
HIV Type 1 pol Gene Diversity and Antiretroviral Drug Resistance Mutations in Santos, Brazil |
ARHR |
|
| Deacon (1995) |
Genomic structure of an attenuated quasispecies of HIV-1 from a blood transfusion donor and recipients. |
Science |
|
| Deeks (1999) |
Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome. |
J Infect Dis |
|
| Delaugerre (2005) |
Selection of a rare resistance profile in an HIV-1-infected patient exhibiting a failure to an antiretroviral regimen including tenofovir DF |
J Clin Virol |
|
| Delaunay (2005) |
Comparative selection of the K65R and M184V/I mutations in human immunodeficiency virus type 1-infected patients enrolled in a trial of first-line triple-nucleoside analog therapy (Tonus IMEA 021). |
J Virol |
|
| Delgado (2001) |
Analysis of HIV type 1 protease and reverse transcriptase sequences from Venezuela for drug resistance-associated mutations and subtype classification: a UNAIDS study |
ARHR |
|
| Delgado (2002) |
Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure |
JAIDS |
|
| Delgado (2004) |
Genotypic(and phenotypic) predictors of a response to DDI monotherapy in ZDV_experienced patients |
Antiviral Therapy |
|
| Demeter (2000) |
Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type I isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260). |
AAC |
|
| Derache (2007) |
Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali |
Antiviral Therapy |
|
| Derache (2008) |
Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006 |
J Antimicrob Chemo |
|
| Descamps (1997) |
Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: In vitro phenotypic and genotypic analyses. |
J Virol |
|
| Deshpande (2004) |
Molecular characterization of HIV type 1 isolates from untreated patients of Mumbai (Bombay) India: and detection of rare resistance mutations. |
ARHR |
|
| Dewhurst (1990) |
Sequence analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14. |
Nature |
|
| Dietrich (1989) |
A highly divergent HIV-2-related isolate. |
Nature |
|
| Dilernia (2007) |
HIV type 1 genetic diversity surveillance among newly diagnosed individuals from 2003 to 2005 in Buenos Aires, Argentina |
ARHR |
|
| Doualla-Bell (2006) |
High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens |
AAC |
|
| Doualla-Bell (2006) |
Impact of human immunodeficiency virus type 1 subtype C on drug resistance mutations in patients from Botswana failing a nelfinavir-containing regimen |
AAC |
|
| Dowling (2002) |
Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants |
AIDS |
|
| Doyon (2005) |
Selection and characterization of HIV-1 showing reduced susceptibility to the non-peptidic protease inhibitor tipranavir. |
Antiviral Res |
|
| Dueweke (1993) |
A mutation in reverse transcriptase of bis(heteroaryl)piperazine- resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitors. |
PNAS |
|
| Dumans (2002) |
Prevalence of protease and reverse transcriptase drug resistance mutations over time in drug-naive human immunodeficiency virus type 1-positive individuals in Rio de Janeiro, Brazil. |
AAC |
|
| Dumans (2004) |
Synonymous genetic polymorphisms within Brazilian human immunodeficiency virus Type 1 subtypes may influence mutational routes to drug resistance. |
J Infect Dis |
|
| Dunne (2001) |
Comparison of genotyping and phenotyping methods for determining susceptibility of HIV-1 to antiretroviral drugs |
AIDS |
|
| Duque (2002) |
Prevalence of drug resistance and HIV-1 subtypes in antiretroviral inexperienced patients, during the year 2000 in Portugal |
Unpublished |
|
| Durant (1999) |
Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial. |
Lancet |
|
| Dykes (2001) |
Impact of clinical reverse transcriptase sequences on the replication capacity of HIV-1 drug-resistant mutants. |
Virology |
|
| Ellenberger (1999) |
Genetic analysis of human immunodeficiency virus in Abidjan, Ivory Coast reveals predominance of HIV type 1 subtype A and introduction of subtype G. |
ARHR |
|
| Ellrodt (1984) |
Isolation of human T-lymphotropic retrovirus (LAV) from Zairian married couple, one with AIDS, one with prodromes. |
Lancet |
|
| Emini (1993) |
HIV and multidrug resistance. |
Nature |
|
| Eshleman (2001) |
Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study). |
J Infect Dis |
|
| Eshleman (2001) |
Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377). |
J Infect Dis |
|
| Eshleman (2002) |
Identification of Ugandan HIV type 1 variants with unique patterns of recombination in pol involving subtypes A and D. |
ARHR |
|
| Eshleman (2002) |
Survival of Ugandan infants with subtype A and D HIV-1 infection (HIVNET 012) |
JAIDS |
|
| Eshleman (2004) |
Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012. |
ARHR |
|
| Eshleman (2004) |
Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine |
JAIDS |
|
| Eshleman (2004) |
Performance of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for sequence-based analysis of diverse human immunodeficiency virus type 1 strains. |
J Clin Microbiol |
|
| Eshleman (2005) |
Limited evolution in the HIV type 1 pol region among acute seroconverters in Pune, India. |
ARHR |
|
| Eshleman (2005) |
Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP |
J Infect Dis |
|
| Eshleman (2006) |
Phenotypic drug resistance patterns in subtype A HIV-1 clones with nonnucleoside reverse transcriptase resistance mutations |
ARHR |
|
| Eshleman (2007) |
Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection |
AIDS |
|
| Evans (1988) |
Characterization of a noncytopathic HIV-2 strain with unusual effects on CD4 expression. |
Science |
|
| Eyer-Silva (2007) |
Autochthonous horizontal transmission of a CRF02_AG strain revealed by a human immunodeficiency virus type 1 diversity survey in a small city in inner state of Rio de Janeiro, Southeast Brazil |
Mem Ins Oswaldo Cruz |
|
| Eyzaguirre (2007) |
Genetic Characterization of HIV-1 Strains Circulating in Kazakhstan |
JAIDS |
|
| Falloon (2000) |
Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: pharmacokinetic drug interactions and antiviral activity. |
Clin Infect Dis |
|
| Fang (2001) |
Analysis of transition from long-term nonprogressive to progressive infection identifies sequences that may attenuate HIV type 1 |
ARHR |
|
| Fang (2004) |
Long-term survivors in Nairobi: complete HIV-1 RNA sequences and immunogenetic associations. |
J Infect Dis |
|
| Fang (2004) |
Recombination following superinfection by HIV-1 |
AIDS |
|
| Fikkert (2003) |
Development of resistance against diketo derivatives of human immunodeficiency virus type 1 by progressive accumulation of integrase mutations |
J Virol |
|
| Fitzgibbon (1992) |
Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidine. |
AAC |
|
| Fitzgibbon (1993) |
Human immunodeficiency virus type 1 pol gene mutations in an AIDS patient treated with multiple antiretroviral drugs. |
J Virol |
|
| Fitzgibbon (1993) |
In vivo prevalence of azidothymidine (AZT) resistance mutations in an AIDS patient before and after AZT therapy. |
ARHR |
|
| Fitzgibbon (2001) |
Emergence of drug resistance mutations in a group of hiv-infected children taking nelfinavir-containing regimens |
ARHR |
|
| Flores (1999) |
HIV-1 subtype F in single and dual infections in Puerto Rico: A potential sentinel site for monitoring novel genetic HIV variants in North America |
Emerg Infect Dis |
|
| Foli (1996) |
In vitro selection and molecular characterization of human immunodeficiency virus type 1 with reduced sensitivity to 9-{2-(phosphonomethoxy)ethyl}adenine (PMEA) |
Antiviral Res |
|
| Fomsgaard (1991) |
A highly divergent proviral DNA clone of SIV from a distinct species of African green monkey. |
Virology |
|
| Fonjungo (2002) |
Human immunodeficiency virus type 1 group m protease in cameroon: genetic diversity and protease inhibitor mutational features |
J Clin Microbiol |
|
| Franchini (1987) |
Genetic analysis of a new subgroup of human and simian T-lymphotropic retroviruses: HTLV-IV, LAV-2, SBL-6669, STLV-III-AGM. |
ARHR |
|
| Franchini (1987) |
Sequence of simian immunodeficiency virus and its relationship to the human immunodeficiency virus. |
Nature |
|
| Franchini (1989) |
Molecular and biological characteristics of a replication competent human immunodeficiency virus type 2 (HIV-2) proviral clone. |
PNAS |
|
| Friend (2004) |
Isolated lopinavir resistance after virological rebound of a ritonavir/lopinavir-based regime |
AIDS |
|
| Fujiwara (1998) |
S-1153 inhibits replication of known drug-resistant strains of human immunodeficiency virus type 1. |
AAC |
|
| Fukasawa (1988) |
Sequence of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV group. |
Nature |
|
| Galabru (1995) |
Nucleotide sequence of the HIV-2 EHO genome, a divergent HIV-2 isolate. |
ARHR |
|
| Galkin (2006) |
Direct Genbank Submission: Sequencing and analysis of full-length HIV-1 CRF06_cpx isolate from Russia. |
unpublished |
|
| Galkin (2006) |
Full-Length Genomic Sequencing and Analysis of Four HIV Type 1 Subtype B Isolates Circulating in the Territory of Russia |
ARHR |
|
| Gallant (2004) |
Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. 903 Study Group. |
JAMA |
|
| Gallant (2005) |
Early Virologic Non-Response to Tenofovir, Abacavir, and Lamivudine in HIV-Infected Antiretroviral Naive Subjects. |
J Infect Dis |
|
| Gao (1992) |
Human infection by genetically diverse SIVSM-related HIV-2 in West Africa. |
Nature |
|
| Gao (1994) |
Genetic diversity of human immunodeficiency virus type 2: Evidence for distinct sequence subtypes with differences in Virus Biology |
J Virol |
|
| Gao (1996) |
The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. |
J Virol |
|
| Gao (1996) |
Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID networks for HIV isolation and characterization. |
J Virol |
|
| Gao (1998) |
A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. |
J Virol |
|
| Gao (1998) |
An isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes. |
J Virol |
|
| Gao (1999) |
Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. |
Nature |
|
| Gao (2001) |
Molecular characterization of a highly divergent HIV type 1 isolate obtained early in the AIDS epidemic from the Democratic Republic of Congo. |
ARHR |
|
| Gao (2001) |
Evidence of two distinct subsubtypes within the HIV-1 subtype A radiation |
ARHR |
|
| Gao (2003) |
Direct Genbank Submission: Complete genomes of HIV-1 subtype C viruses in South Africa. |
unpublished |
|
| Gao (2005) |
Direct Genbank Submission: Recombination in human immunodefeciency virus type 2. Complete Genome. |
unpublished |
|
| Garcia-Bujalance (2005) |
Comparison between sequence analysis and a line probe assay for testing genotypic resistance of human immunodeficiency virus type 1 to antiretroviral drugs. |
J Clin Microbiol |
|
| Gatanaga (1999) |
Anti-HIV effect of saquinavir combined with ritonavir is limited by previous long-term therapy with protease inhibitors. |
ARHR |
|
| Gibb (2002) |
Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial). |
Antiviral Therapy |
|
| Gittens (2003) |
The molecular epidemiology and drug resistance determination of HIV type 1 subtype B infection in Barbados |
ARHR |
|
| Gody (2008) |
High Prevalence of Antiretroviral Drug Resistance Mutations in HIV-1 Non-B Subtype Strains From African Children Receiving Antiretroviral Therapy Regimen According to the 2006 Revised WHO Recommendations |
JAIDS |
|
| Goethals (2008) |
Resistance mutations in HIV-1 integrase selected with Elvitegravir confer reduced susceptibility to a wide range of integrase inhibitors |
J Virol |
|
| Gong (2000) |
In vitro resistance profile of the human immunodeficiency virus type 1 protease inhibitor BMS-232632. |
AAC |
|
| Gonzales (2001) |
HIV-1 reverse transcriptase and protease subtypes: classification, amino acid mutation patterns, and prevalence in a Northern California clinic-based population. |
J Infect Dis |
|
| Gonzales (2002) |
A comprehensive multidrug-resistant HIV-1 reverse transcriptase (RT) panel |
unpublished |
|
| Gonzales (2003) |
Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors |
AIDS |
|
| Gonzales (2003) |
Protease and reverse transcriptase mutation patterns in HIV-1 isolates from heavily treated persons: Cmparison of isolates from northern California with isolates from other regions |
ARHR |
|
| Gonzales (2003) |
Colinearity of reverse transcriptase inhibitor resistance mutations detected by population-based sequencing. |
JAIDS |
|
| Gonzalez (2003) |
Epidemiological and molecular characteristcs of HIV and HTLV infection in Equatorial Guinea, 1996-1998. |
Unpublished |
|
| Goodman (2008) |
Integrase Inhibitor Resistance Involves Complex Interactions Among Primary and Secondary Resistance Mutations: A Novel Mutation L68V/I Associates with E92Q and Increases Resistance |
HIV DRW 2008 |
|
| Gordon (2003) |
Molecular characteristics of human immunodeficiency virus type 1 subtype C viruses from KwaZulu-Natal, South Africa: implications for vaccine and antiretroviral control strategies. |
J Virol |
|
| Graf (1998) |
Cloning and characterization of a virtually full-length HIV-1 genome from a subtype B'-Thai strain representing the most prevalent B-clade isolate in china. |
ARHR |
|
| Grisson (2004) |
Infectious molecular clone of a recently transmitted pediatric human immunodeficiency virus clade C isolate from Africa: evidence of intraclade recombination |
J Virol |
|
| Groenink (1991) |
Phenotypic heterogeneity in a panel of infectious molecular human immunodeficiency virus type 1 clones derived from a single individual. |
J Virol |
|
| Grossman (2002) |
Sequences from patients infected with non subtype B HIV-1 from Israel |
Unpublished |
|
| Grossman (2004) |
Mutation D30N is not preferentially selected by human immunodeficiency virus type 1 subtype C in the development of resistance to nelfinavir. |
AAC |
|
| Gu (1994) |
Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency resistance to 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine. |
AAC |
|
| Gulick (2004) |
Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection. |
N Engl J Med |
|
| Gunthard (1998) |
Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy. |
J Virol |
|
| Gurgo (1988) |
Envelope sequences of two new United States HIV-1 isolates. |
Virology |
|
| Gurtler (1994) |
A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. |
J Virol |
|
| Gurusinghe (1995) |
Reverse transcriptase mutations in sequential HIV-1 isolates in a patient with AIDS. |
J Med Virol |
|
| Hai-Long (2007) |
Genetic characterization of CRF01_AE full-length human immunodeficiency virus type 1 sequences from Fujian, China |
ARHR |
|
| Hammer (1997) |
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. |
N Engl J Med |
|
| Han (2007) |
Genotypic resistance mutations to antiretroviral drugs in treatment-naive HIV/AIDS patients living in Liaoning Province, China: baseline prevalence and subtype-specific difference |
ARHR |
|
| Handema (2002) |
Prevalence of drug-resistance-associated mutations in antiretroviral drug-naive Zambians infected with subtype C HIV-1. |
ARHR |
|
| Hanna (2003) |
Drug-selected resistance mutations and non-B subtypes in antiretroviral-naive adults with established human immunodeficiency virus infection. |
J Infect Dis |
|
| Hanna (2000) |
Patterns of resistance mutations selected by treatment of human immunodeficiency virus type 1 infection with zidovudine, didanosine, and nevirapine. |
J Infect Dis |
|
| Harrigan (1996) |
Significance of amino acid variation at human immunodeficiency virus type 1 reverse transcriptase residue 210 for zidovudine susceptibility. |
J Virol |
|
| Harrigan (2002) |
A mutation in the 3' region of the human immunodeficiency virus type 1 reverse transcriptase (Y318F) associated with nonnucleoside reverse transcriptase inhibitor resistance |
J Virol |
|
| Harrigan (2005) |
Rare mutations at codon 103 of HIV-1 reverse transcriptase can confer resistance to non-nucleoside reverse transcriptase inhibitors |
AIDS |
|
| Harris (2005) |
Genomic Characterization of a Novel HIV Type 1 B/G Intersubtype Recombinant Strain from an Injecting Drug User in Germany |
ARHR |
|
| Harris (2002) |
Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate. |
ARHR |
|
| Harris (2003) |
A cluster of HIV type 1 subtype C sequences from Ethiopia, observed in full genome analysis, is not sustained in subgenomic regions |
ARHR |
|
| Hasegawa (1989) |
Genomic divergence of HIV-2 from Ghana. |
ARHR |
|
| Haubrich (1999) |
A phase II safety and efficacy study of apmrenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience. |
AIDS |
|
| Hazuda (2004) |
A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase |
PNAS |
|
| Heilek-Snyder (2003) |
In vitro cross resistance profile of RO033-4649 against a panel of multiply-substituted protease inhibitor-resistant viruses: role of common protease resistance mutations |
Antiviral Therapy |
|
| Heredia (1997) |
Evidence of HIV-2 infection in Equatorial Guinea (Central Africa): Partial genetic analysis of a B subtype virus. |
ARHR |
|
| Heredia (1997) |
Genetic analysis of an HIV type 2 subtype B virus from a Spanish individual with AIDS. |
ARHR |
|
| Herring (2001) |
Direct Genbank Submission: Natural Variation in HIV-1 Integrase in Australia. |
unpublished |
|
| Herring (2004) |
Potential drug resistance polymorphisms in the integrase gene of HIV type 1 subtype A |
ARHR |
|
| Hertogs (1998) |
A rapid method for simultaneous detection of phenotypic resistance to protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs. |
AAC |
|
| Hertogs (2000) |
A novel human immunodeficiency virus type 1 reverse transcriptase mutational pattern confers phenotypic lamivudine resistance in the absence of mutation 184V. |
AAC |
|
| Hicks (2006) |
Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSista |
Lancet |
|
| Hierholzer (2002) |
Molecular epidemiology of HIV type 1 in Ecuador, Peru, Bolivia, Uruguay, and Argentina |
ARHR |
|
| Hierholzer (2002) |
HIV type 1 strains from east and west Africa are intermixed in Sudan. |
ARHR |
|
| Hirsch (1987) |
The genome organization of STLV-3 is similar to that of the AIDS virus except for a truncated transmembrane protein. |
Cell |
|
| Hirsch (1989) |
An African primate lentivirus (SIVsm) closely related to HIV-2. |
Nature |
|
| Hirsch (1993) |
A distinct African lentivirus from Sykes monkeys. |
J Virol |
|
| Hirsch (1995) |
Induction of AIDS by simian immunodeficiency virus from an African green monkey: Species-specific variation in pathogenicity correlates with the extent of in vivo replication. |
J Virol |
|
| Hirsch (1997) |
A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3. |
J Virol |
|
| Hirsch (1999) |
Characterization of a novel simian immunodeficiency virus (SIV) from L'Hoest monkeys (Cercopithecus l'hoesti): implications for the origins of SIVmnd and other primate lentiviruses. |
J Virol |
|
| Ho (1994) |
Characterization of human immunodeficiency virus type1 variants with increased resistance to a C2-symmetric protease inhibitor. |
J Virol |
|
| Hoelscher (2001) |
High proportion of unrelated HIV-1 intersubtype recombinants in the Mbeya region of southwest Tanzania |
AIDS |
|
| Holguin (1999) |
Human immunodeficiency virus type 1 subtypes circulating in Portugal. |
unpublished |
|
| Holguin (2000) |
Recombinant human immunodeficiency viruses type 1 circulating in Spain. |
ARHR |
|
| Holguin (2000) |
Protease gene analysis of HIV Type 1 non-B subtypes in Spain |
ARHR |
|
| Holguin (2001) |
Prevalence of human immunodeficiency virus type 1 (HIV-1) Non-B subtypes in foreigners living in Madrid, Spain, and comparison of the performances of the AMPLICOR HIV-1 MONITOR version 1.0 and the new automated version 1.5. |
J Clin Microbiol |
|
| Holguin (2002) |
High prevalence of HIV-1 subtype G and natural polymorphisms at the protease gene among HIV-infected immigrants in Madrid |
AIDS |
|
| Holguin (2002) |
HIV-1 subtype J recombinant viruses in Spain |
ARHR |
|
| Holguin (2003) |
HIV-positive immigrants in the Canary Islands, Spain: implications for public health in Europe |
HIV Clin Trials |
|
| Holguin (2004) |
Impact of frequent natural polymorphisms at the protease gene on the in vitro susceptibility to protease inhibitors in HIV-1 non-B subtypes. |
J Clin Virol |
|
| Holguin (2005) |
Heterogeneous nature of HIV-1 recombinants spreading in Spain |
J Med Virol |
|
| Holguin (2005) |
Differences in the length of gag proteins among different HIV type 1 subtypes |
ARHR |
|
| Holguin (2008) |
Genetic characterization of complex inter-recombinant HIV-1 strains circulating in Spain and reliability of distinct rapid subtyping tools |
J Med Virol |
|
| Holzmayer (2005) |
Near-full-length genomic sequence of a human immunodeficiency type 1 subtype g strain from cameroon |
ARHR |
|
| Hombrouck (2008) |
Mutations in human immunodeficiency virus type 1 integrase confer resistance to the naphthyridine L-870,810 and cross-resistance to the clinical trial drug GS-9137 |
AAC |
|
| Hooker (1996) |
An in vivo mutation from leucine to tryptophan at position 210 in human immunodeficiency virus type 1 reverse transcriptase contributes to high-level resistance to 3'-azido-3'-deoxythymidine |
J Virol |
|
| Howard (1996) |
Genomic structure and nucleotide sequence analysis of a new HIV type 1 subtype A strain from Nigeria. |
ARHR |
|
| Hsu L (2005) |
Characterization of mutations in CRF01_AE virus isolates from antiretroviral treatment naive and experienced patients in Singapore |
JAIDS |
|
| Huang (2003) |
Sequence characterization of the protease and partial reverse transcriptase proteins of the NED panel, an international HIV type 1 subtype reference and standards panel. |
ARHR |
|
| Huang (2006) |
Genetic characterization of three CRF01_AE full-length HIV type 1 sequences from Fujian Province, China |
Chin Med J (Engl) |
|
| Huang (1998) |
Direct Genbank Submission: Complete sequence of type B HIV-1 Taiwan strain. |
unpublished |
|
| Huang (1999) |
Complex interactions involving multiple amino acid substitutions alter NNRTI susceptibility [abstract 73]. |
Antiviral Therapy |
|
| Huang (2000) |
A novel HIV-1 RT mutation (M230L) confers NNRTI resistance and dose-dependent stimulation of replication [abstract 30]. |
Antiviral Therapy |
|
| Huang (2003) |
Amino acid substitutions at position 190 of human immunodeficiency virus type 1 reverse transcriptase increase susceptibility to delavirdine and impair virus replication. |
J Virol |
|
| Huang (1998) |
Characterization of gag and pol sequences from long-term survivors of human immunodeficiency virus type 1 infection. |
Virology |
|
| Huet (1989) |
A highly defective HIV-1 strain isolated from a healthy Gabonese individual presenting an atypical Western blot. |
AIDS |
|
| Huet (1990) |
Genetic organization of a chimpanzee lentivirus related to HIV-1. |
Nature |
|
| Hu (2003) |
Characterization and comparison of recombinant simian immunodeficiency virus from drill (Mandrillus leucophaeus) and mandrill (Mandrillus sphinx) isolates. |
J Virol |
|
| Hunt (2003) |
Characterisation of near-full length genome sequences of three South African human immunodeficiency virus type 1 subtype C isolates |
Virus Genes |
|
| Ibanez (2000) |
Human immunodeficiency virus type 1 population bottleneck during indinavir therapy causes a genetic drift in the env quasispecies. |
J Gen Virol |
|
| Ibe (2008) |
Trend of drug-resistant HIV type 1 emergence among therapy-naive patients in Nagoya, Japan: an 8-year surveillance from 1999 to 2006 |
ARHR |
|
| Imamichi (2000) |
High-level resistance to 3'-azido-3'-deoxythymidine due to a deletion in the reverse transcriptase gene of human immunodeficiency virus type 1. |
J Virol |
|
| Ishikawa (1988) |
Isolation and characterization of HIV-2 from an AIDS patient in Ghana. |
AIDS |
|
| Iversen (1996) |
Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy. |
J Virol |
|
| Izopet (1998) |
Decay of HIV-1 DNA in patients receiving suppressive antiretroviral therapy. |
JAIDS |
|
| Jackson (2000) |
Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission. |
AIDS |
|
| Jacobs (2007) |
Complete genome sequencing of a non-syncytium-inducing HIV type 1 subtype D strain from Cape Town, South Africa |
ARHR |
|
| Jacobsen (1995) |
Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959. |
Virology |
|
| Janini (1996) |
Identification of single and dual infections with distinct subtypes of human immunodeficiency virus type 1 by using restriction fragment length polymorphism analysis. |
Virus Genes |
|
| Janssens (1999) |
HIV-1 subtype H near-full genome reference strains and analysis of subtype-H-containing inter-subtype recombinants. |
AIDS |
|
| Janssens (2000) |
Near full-length genome analysis of HIV type 1 CRF02.AG subtype C and CRF02.AG subtype G recombinants |
ARHR |
|
| Jellinger (1997) |
A novel approach to assessing the drug susceptibility and replication of human immunodeficiency virus type 1 isolates. |
J Infect Dis |
|
| Jin (1994) |
Mosaic genome structure of simian immunodeficiency virus from west African green monkeys. |
EMBO J |
|
| Johnson (1990) |
Simian immunodeficiency viruses from African green monkeys display unusual genetic diversity. |
J Virol |
|
| Johnston (2003) |
Preliminary characterization of a newly described protease substrate cleft mutation at position 23 |
Antiviral Therapy |
|
| Johnston (2005) |
Panel of prototypical infectious molecular HIV-1 clones containing multiple nucleoside reverse transcriptase inhibitor resistance mutations. |
AIDS |
|
| Johnston. E (2003) |
High frequency of syncytium-inducing and CXCR4-tropic viruses among human immunodeficiency virus type 1 subtype C-infected patients receiving antiretroviral treatment. |
J Virol |
|
| Jonassen (1997) |
Sequence analysis of HIV-1 group ) from Norwegian patients infected in the 1960s. |
Virology |
|
| Jonassen (2000) |
Intersubtype recombinant HIV type 1 involving HIV-MAL-like and subtype H-like sequence in four Norwegian cases. |
ARHR |
|
| Jones (2005) |
Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine |
ARHR |
|
| Jones (2007) |
Resistance Profile of HIV-1 Mutants in vitro Selected by the HIV-1 Integrase Inhibitor, GS-9137 (JTK-303). Poster abstract #627. |
14th CROI |
|
| Jones (2009) |
Preclinical evaluation of GS-9160, a novel inhibitor of human immunodeficiency virus type 1 integrase |
AAC |
|
| Jorgensen (2000) |
Genotypic and phenotypic nevirapine resistance correlates with virological failure during salvage therapy including abacavir and nevirapine |
Antiviral Therapy |
|
| Jorgensen (2003) |
Prevalence of drug resistance mutations and non-B subtypes in newly diagnosed HIV-1 patients in Denmark |
Scand J Infect Dis |
|
| K'Aluoch (2005) |
Characterization of HIV-1 Subtypes and Recombinants in a Uganda Cohort by use of the gag, nef and pol Genes. |
Unpublished |
|
| Kagan (2005) |
Structural analysis of an HIV-1 protease I47A mutant resistant to the protease inhibitor lopinavir |
Protein Sci |
|
| Kandathil (2008) |
Genotypic resistance profile of HIV-1 protease gene: A preliminary report from Vellore, south India |
Indian J Med Microbi |
|
| Kane (2001) |
Full-length genome sequencing of HIV type 1 group O viruses isolated from a heterosexual transmission cluster in Senegal. |
ARHR |
|
| Kantor (2002) |
Evolution of primary protease inhibitor resistance mutations during protease inhibitor salvage therapy |
AAC |
|
| Kantor (2002) |
HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy. |
ARHR |
|
| Kantor (2005) |
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a golbal collaboration. |
PLoS Med |
|
| Kassu (2006) |
Molecular Epidemiology of HIV-1 in Treatment-Naive Patients in North Ethiopia |
ARHR |
|
| Katzenstein (2000) |
Virologic and CD4+ cell responses to new nucleoside regimens: switching to stavudine or adding lamivudine after prolonged zidovudine treatment of human immunodeficiency virus infection. ACTG 302 Study Team. AIDS Clinical Trials Group. |
ARHR |
|
| Katzenstein (2001) |
Misc Isolates from Zimbabwe |
Unpublished |
|
| Katzenstein (2001) |
Virologic and CD4 cell response to zidovudine or zidovudine and lamivudine following didanosine treatment of human immunodeficiency virus infection. |
ARHR |
|
| Katzenstein (2005) |
Patients from Denmark infected with non-B HIV-1. |
Unpublished |
|
| Kavlick (1998) |
Emergence of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 variants, viral sequence variation, and disease progression in patients receiving antiretroviral chemotherapy. |
J Infect Dis |
|
| Kaye (2002) |
Observations of HIV-1 genotypic drug resistance in a trial of four reverse transcriptase inhibitors (Quattro Trial) |
Antiviral Therapy |
|
| Keele (2006) |
Chimpanzee reservoirs of pandemic and nonpandemic HIV-1 |
Science |
|
| Kellam (1992) |
Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine. |
PNAS |
|
| Kellam (1994) |
Zidovudine treatment results in the selection of human immunodeficiency virus type 1 variants whose genotypes confer increasing levels of drug resistance. |
J Gen Virol |
|
| Kellam (1994) |
Recombinant virus assay: a rapid, phenotypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates. |
AAC |
|
| Kemp (1998) |
A novel polymorphism at codon 333 of human immunodeficiency virus type 1 reverse transcriptase can facilitate dual resistance to zidovudine and L-2',3'-dideoxy-3'-thiacytidine. |
J Virol |
|
| Kempf (2001) |
Identification of genotypic changes in human immunodeficiency virus protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients |
J Virol |
|
| Kestler (1988) |
Comparison of simian immunodeficiency virus isolates. |
Nature |
|
| Kestler (1990) |
Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. |
Science |
|
| Khurana (2002) |
Direct Genbank Submission: Complete Genome sequences of HIV-1 01IN565 clone isolates from India. |
unpublished |
|
| Kiepiela (2004) |
Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. |
Nature |
|
| Kijak (2001) |
Resistance profiles to antiretroviral drugs in HIV-1 drug-naïve patients in Argentina |
Antiviral Therapy |
|
| Kijak (2004) |
Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa |
ARHR |
|
| Kimata (1998) |
A lymph node-derived cytopathic simian immunodeficiency virus Mne variant replicates in nonstimulated peripheral blood mononuclear cells. |
Virology |
|
| King (2006) |
Phenotypic Susceptibility to TMC-114 and Tipranavir Before and After Lopinavir/ritonavir-based Treatment in Subjects Demonstrating Evolution of Lopinavir Resistance |
HIV DRW 2006 |
|
| Kinomoto (2005) |
HIV-1 proteases from drug-naive West African patients are differentially less susceptible to protease inhibitors |
Clin Infect Dis |
|
| Kirchhoff (1990) |
A novel proviral clone of HIV-2: biologic and phylogenetic relationship to other primate immunodeficiency viruses. |
Virology |
|
| Kleim (1996) |
Selective pressure of a quinozaline nonnucleoside inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) on HIV-1 replication results in the emergence of nucleoside RT-inhibitor-specific (RT Leu-74-->Val or Ile and Val-75-->Le |
PNAS |
|
| Koch (2001) |
Genetic analysis of HIV type 1 strains in Bujumbura (Burundi): Predominance of subtype C variant |
ARHR |
|
| Koizumi (2006) |
Emergence of Antiretroviral Therapy Resistance-Associated Primary Mutations Among Drug-Naive HIV-1-Infected Individuals in Rural Western Cameroon. |
JAIDS |
|
| Kong (1988) |
West African HIV-2-related human retrovirus with attenuated cytopathicity. |
Science |
|
| Konings (2003) |
HIV-1 CRF02_AG Strains in Cameroon Share Common Recombination Breakpoints in the Reverse Transcriptase Gene |
unpublished |
|
| Konings (2004) |
Protease mutations in HIV-1 Non-B strains infecting drug-naive villagers of Cameroon |
ARHR |
|
| Konings (2004) |
V118I substitution in the reverse transcriptase gene of HIV type 1 CRF02_AG strains infecting drug-naive individuals in Cameroon |
ARHR |
|
| Korber (2003) |
HIV HLA epitope mapping from Durban South Africa |
unpublished |
|
| Koulinska (2001) |
A new human immunodeficiency virus type 1 circulating recombinant form from Tanzania |
ARHR |
|
| Koulinska (2002) |
Common genetic arrangements among human immunodeficiency virus type 1 subtype A and D recombinant genomes vertically transmitted in Tanzania |
ARHR |
|
| Koulinska (2003) |
Hypermutation of HIV type 1 genomes isolated from infants soon after vertical infection |
ARHR |
|
| Kousiappa (2009) |
Genetic analysis of HIV type 1 strains from newly infected untreated patients in Cyprus: high genetic diversity and low prevalence of drug resistance |
ARHR |
|
| Koyanagi (1987) |
Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. |
Science |
|
| Kozal (1996) |
Extensive polymorphisms observed in HIV-1 clade-B protease gene using high-density oligonucleotide arrays. |
Nat Med |
|
| Kreutz (1992) |
Analysis of the envelope region of the highly divergent HIV-2-ALT isolate extends the known range of variability within the primate immunodeficiency viruses. |
ARHR |
|
| Kristiansen (2005) |
Genetic evolution of HIV in patients remaining on a stable HAART regimen despite insufficient viral suppression |
Scand J Infect Dis |
|
| Kuehnel (1990) |
Nucleotide sequence of HIV-2D194, an isolate from a Gambian case of 'neuro-AIDS', which showed excellent growth in macrophages. |
Nucleic Acids Res |
|
| Kuhnel (1989) |
Molecular cloning of two west African human immunodeficiency virus type 2 isolates that replicate well in macrophages: a Gambian isolate from a patient with neurological acquired immunodeficiency syndrome, and a highly divergent Ghanian isolate. |
PNAS |
|
| Kumar (1990) |
Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate. |
J Virol |
|
| Kuritzkes (2004) |
Rate of Thymidine analogue resistance mutation accumulation with Zidovudine- or Stavudine-based regimens |
JAIDS |
|
| Kurle (2007) |
Emergence of NNRTI Drug Resistance Mutations after Single-Dose Nevirapine Exposure in HIV Type 1 Subtype C-Infected Infants in India |
ARHR |
|
| Kusagawa (2001) |
Isolation and characterization of a full-length molecular DNA clone of Ghanaian HIV type 1 intersubtype A/G recombinant CRF02_AG, which is replication competent in a restricted host range |
ARHR |
|
| Kusagawa (2002) |
Isolation and characterization of replication-competent molecular DNA clones of HIV type 1 CRF01_AE with different coreceptor usages |
ARHR |
|
| Kusagawa (2003) |
Identification of HIV type 2 subtype B transmission in East Asia |
ARHR |
|
| Lacey (1994) |
Novel mutation (V75T) in human immunodeficiency virus type 1 reverse transcriptase confers resistance to 2',3'-didehydro-2',3'- dideoxythymidine in cell culture. |
AAC |
|
| Laeyendecker (2005) |
Molecular epidemiology of HIV-1 subtypes in southern China |
JAIDS |
|
| Lahuerta (2008) |
Rapid Spread and Genetic Diversification of HIV Type 1 Subtype C in a Rural Area of Southern Mozambique |
ARHR |
|
| Lall (2008) |
Profile of primary resistance in HIV-1-infected treatment-naive individuals from Western India |
ARHR |
|
| Lam (2003) |
Amprenavir Rissistance imparted by the I50V mutation in HIV-1 protease can be suppressed by the N88S mutation |
Clin Infect Dis |
|
| Lama (2006) |
Linking HIV and antiretroviral drug resistance surveillance in Peru: a model for a third-generation HIV sentinel surveillance |
JAIDS |
|
| Lan (2003) |
HIV type 1 isolates from 200 untreated individuals in Ho Chi Minh city(Vietnam): ANRS 1257 Study. Large Predominance of CRF01_AE and Presence of Major Resistance Mutations to Antiretroviral Drugs. |
ARHR |
|
| Land (2008) |
Full-length HIV type 1 proviral sequencing of 10 highly exposed women from Nairobi, Kenya reveals a high proportion of intersubtype recombinants |
ARHR |
|
| Lanier (2004) |
Effect of concurrent zidovudine use on the resistance pathway selected by abacavir-containing regimens. |
HIV Med |
|
| Larder (1989) |
HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. |
Science |
|
| Larder (1990) |
Susceptibility of zidovudine-susceptible and -resistant human immunodeficiency virus isolates to antiviral agents determined using a quantitative plaque reduction assay. |
AAC |
|
| Larder (1991) |
Zidovudine-resistant human immunodeficiency virus selected by passage in cell culture. |
J Virol |
|
| Larder (1992) |
3'-Azido-3'-Deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors. |
AAC |
|
| Larder (1993) |
Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro. |
Nature |
|
|
